Highlights ChitogenX Inc.

Equities

CHGX

CA1699161032

Market Closed - Canadian Securities Exchange Other stock markets 15:12:25 03/05/2024 BST			5-day change	1st Jan Change
0.045 ^CAD	0.00%		+12.50%	-30.77%

02-28	Chitogenxinc. Announces Resignation of Philippe Deschamps from the Board of Directors	CI
02-28	Chitogenx Inc. Announces CEO Changes	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

ChitogenX Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended October 31, 2023	01-02	CI
Chitogenx Inc. Demonstrates ORTHO-R Efficacy and Osteoarthritidevelopment in Large Animal Study	11-09	CI
ChitogenX Inc. Reports Earnings Results for the Second Quarter and Six Months Ended July 31, 2023	29/09/23	CI
ChitogenX Inc. Receives Notice of Allowance for Key Patent in United States and Canada	28/09/23	CI
ChitogenX Concluded Enrolment For Its U.S. Multi-site Rotator Cuff Tear Repair Phase I/II Clinical Trial	26/09/23	MT
Chitogenx Concludes Enrolment for Its U.S. Phase I/II Rotator Cuff Tear Repair Clinical Trial	26/09/23	CI
ChitogenX Reports Q1 Results	30/06/23	MT
ChitogenX Inc. Reports Earnings Results for the First Quarter Ended April 30, 2023	29/06/23	CI
ChitogenX Inc. Reports Earnings Results for the Full Year Ended January 31, 2023	31/05/23	CI
ChitogenX Inc. Demonstrates Ortho-R Residency Properties in Meniscus Study	14/02/23	CI
ChitogenX Reports Loss for Fiscal Q3, Higher Expenses	29/12/22	MT
ChitogenX Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended October 31, 2022	28/12/22	CI
Chitogenx Successfully Completes Initial Portion of Its U.S. Phase I/Ii Rotator Cuff Repair Clinical Trial	09/11/22	CI
ChitogenX Inc. Up 3.5% as Signs MoU With California Medical Innovations Institute	19/10/22	MT
ChitogenX Inc. Signs Memorandum of Understanding with California Medical Innovations Institute	19/10/22	CI
ChitogenX Inc. Launching Second Orthopedic Development Program In Meniscus Repair	13/10/22	MT
ChitogenX Inc. Launches Second Orthopedic Development Program in Meniscus Repair	13/10/22	CI
ChitogenX Inc. to Pursue Sales of Medical Grade Chitosen As New Near Term Revenue Initiative	05/10/22	MT
ChitogenX Inc. Reports Earnings Results for the Second Quarter and Six Months Ended July 31, 2022	28/09/22	CI
Ortho Regenerative Technologies Announces Enrollment of First Patient in US Clinical Trial	27/07/22	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights ChitogenX Inc.

Equities

CHGX

CA1699161032

Highlights

Filters